Nuvation Bio share price logo

Nuvation Bio

NYSE: NUVB

Mid Cap

$5.74

+0.01

(+0.17%)

as on

Nuvation Bio Stock Performance

as on September 26, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $5.67
    $5.83
    downward going graph

    1.22%

    Downside

    1.57%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.00
    $9.75
    downward going graph

    47.82%

    Downside

    69.86%

    Upside

    downward going graph

Nuvation Bio share price movements today

Previous Close
$5.73
Open
$5.73
Volume
2.6M
Market Cap
$2.0B
Day's Low - High
$5.67 - $5.83
52 Week Low - High
$3.00 - $9.75

Nuvation Bio Historical Returns

1 Month Return
-17.53 %
3 Month Return
+ 1.59 %
1 Year Return
+ 79.38 %
3 Year Return
+ 312.95 %
5 Year Return
-38.54 %

Nuvation Bio Stock Fundamentals & Key Indicators

Check Nuvation Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.0B

EPS (TTM)

-0.4345

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-13.19

Industry PE ratio

-12.76

PEG Ratio

-0.40333837459303556

EBITDA

-127.0M

Revenue (TTM)

169.9M

Profit Margin

93.94%

Return On Equity TTM

-49.73%

Nuvation Bio Stock Valuation

Track how Nuvation Bio P/E has moved over time to understand its valuation trends.

Nuvation Bio in the last 5 years

  • Overview

  • Trends

Lowest (-19.37x)

December 31, 2021

Today (-14.93x)

December 31, 2025

Industry (-12.76x)

December 31, 2025

Highest (-1.26x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -14.93x

Nuvation Bio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nuvation Bio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$2.0B-38.54%-13.1993.94%0.00%
Neutral$77.8B-53.76%-24.41-12.57%0.00%
StrongBuy$132.4B186.58%30.1686.04%0.00%
Buy$82.8B23.34%19.0184.86%0.46%

Stock Returns calculator for Nuvation Bio Stock including INR - Dollar returns

The Nuvation Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Nuvation Bio investment value today

Current value as on today

₹1,93,611

Returns

₹93,611

(+93.61%)

Returns from Nuvation Bio Stock

₹79,375 (+79.38%)

Dollar Impact

₹14,236 (+14.24%)

Analyst Recommendation on Nuvation Bio Stock

Based on 6 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 6 analysts, 100% of analysts recommend a 'BUY' rating for Nuvation Bio. Average target price of $13.1

Nuvation Bio Share Price Target

Get share price movements and forecasts by analysts on Nuvation Bio.

What analysts predicted

56.18%UPSIDE

Target Price

$13.1

Current Price

$5.74

Analyzed by

6 Analysts

High

$21

Target

$13.10

Low

$11

Nuvation Bio target price $13.1, a slight upside of 56.18% compared to current price of $5.74. According to 6 analysts rating.

Indian Investors' Interest in Nuvation Bio Stock

Search interest for Nuvation Bio Stock has decreased by -24% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-24% versus previous 30 day period

Nuvation Bio Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
1
0
5
3
4
13
41
83
31
Gross Profit
-
0
0
1
0
2
9
41
77
30
Operating Income
-20
-470
-48
-53
-59
-63
-56
-34
3
-51
EBITDA
-14
-462
-40
-49
-52
-58
-54
-29
12
-55
Interest Expense
-
0
0
0
0
0
6
6
6
6
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-14
-462
-41
-49
-53
-59
-55
-36
5
-62
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-14
-462
-41
-49
-53
-59
-55
-36
5
-62
Net Profit Margin
0.00%
6.13%
-108.39%
26.18%
32.10%
46.70%
74.47%
98.99%
93.25%
97.13%

Nuvation Bio Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
7
62
Gross Profit
-
-
0
-
-
-
0
54
Operating Income
0
-32
-43
-93
-119
-99
-592
-213
EBITDA
-
-32
-41
-86
-104
-75
-566
-189
Interest Expense
-
-
-
-
-
-
0
13
Depreciation
0
0
0
0
0
0
0
1
Income Before Tax
0
-33
-41
-86
-104
-75
-567
-204
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
0
-33
-41
-86
-104
-75
-567
-204
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
10.10%
86.58%

Nuvation Bio Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-14
-462
-41
-49
-53
-59
-55
168
5
-5
Operating Cash Flow
-15
-37
-31
-46
-42
-48
-52
-29
5
-5
Investing Cash Flow
7
34
29
51
54
54
-96
87
-43
5
Financing Cash Flow
0
2
-1
0
0
193
0
8
0
170
Change in Cash
-8
0
-4
5
12
199
-149
65
-38
171

Nuvation Bio Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-33
-41
-86
-104
-75
-567
-204
Operating Cash Flow
0
-24
-36
-68
-96
-67
-130
-173
Investing Cash Flow
-
-115
-70
-454
63
8
122
99
Financing Cash Flow
0
143
133
625
1
0
0
202
Change in Cash
0
3
26
102
-31
-58
-6
128

Mutual Funds that own Nuvation Bio Stock

Check out the Mutual Funds with significant holdings in Nuvation Bio.

Funds
Holdings
Shares Held
Fidelity Mt. Vernon Street Trust
7.432524%
26097321
VANGUARD INDEX FUNDS
3.221932%
11312954
Fidelity Salem Street Trust
0.771997%
2710661
Fidelity Concord Street Trust
0.646832%
2271179
American Century Mutual Funds, Inc.
0.621007%
2180500

Global Institutional Holdings in Nuvation Bio

Funds
Holdings
Fidelity Mt. Vernon Street Trust
7.43%
iShares
4.26%
Vanguard
4.08%
VANGUARD INDEX FUNDS
3.22%
Otello Stampacchia
2.3%

Nuvation Bio News & Key Events

  • img

    Today's Timeline - 25 June

    Thu, 08:12 PM

    -

    Nuvation Bio announces intent to raise $230 million through convertible senior notes offering, causing stock to drop over 12%.

Insights on Nuvation Bio

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NUVB has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, NUVB stock has moved up by 79.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 695.5% return, outperforming this stock by 616.4%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 83.22M → 31.68M (in $), with an average decrease of 61.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 5.39M → -62.84M (in $), with an average decrease of 1264.4% per quarter

About Nuvation Bio

Nuvation Bio Inc. functions as a clinical-stage biopharmaceutical enterprise committed to discovering and advancing therapeutic solutions for oncological conditions. Its foremost experimental compound, NUV-422, is a small molecule designed to inhibit cyclin-dependent kinases (CDK)2, CDK4, and CDK6. The company's development pipeline further encompasses NUV-868, an orally administered, selective small molecule BET inhibitor that epigenetically influences proteins critical for tumor proliferation and cellular differentiation; NUV-569, a unique oral small molecule targeting the Wee1 kinase to facilitate DNA damage repair; and NUV-1182, an antagonist of adenosine receptors. Additionally, Nuvation Bio is progressing a sophisticated drug-drug conjugate (DDC) platform, engineered to deliver a poly ADP ribose polymerase (PARP) inhibitor in conjunction with existing anti-cancer warheads, particularly for the treatment of ER-positive breast and ovarian cancers. Established in 2018, the firm was initially named RePharmation Inc. before rebranding as Nuvation Bio Inc. in April 2019, and its central operations are based in New York, New York.
OrganisationNuvation Bio
Headquarters1500 Broadway, New York City, NY, 10036, US
IndustryBiotechnology
CEODavid T. Hung
E-voting on sharesClick here to vote

Key Management of Nuvation Bio

Name

Title

Dr. Stephen Dang Ph.D.

Chief Legal Officer & Corporate Secretary

Ms. Stacy Markel

Chief People Officer

Ms. Colleen Sjogren

Chief Commercial Officer

Dr. David T. Hung M.D.

Founder, President, CEO & Chairman

Mr. Philippe Pierre Sauvage

CFO & Principal Financial Officer

Dr. Gary Hattersley Ph.D.

Chief Scientific Officer

Mr. Moses Makunje CPA

VP of Finance and Principal Accounting & Financial Officer

Dr. David C. Hanley Ph.D.

Chief Technical Operations Officer

Robert DeVita

Vice President of Corporate Development & Investor Relations

Ms. Kerry A. Wentworth

Chief Regulatory Officer

FAQs

What is Nuvation Bio share price today?

Nuvation Bio share price today is $5.74 as on at the close of the market. Nuvation Bio share today touched a day high of $5.83 and a low of $5.67.

What is the 52 week high and 52 week low for Nuvation Bio share?

Nuvation Bio share touched a 52 week high of $9.75 on and a 52 week low of $3.00 on . Nuvation Bio stock price today i.e. is closed at $5.74,which is 41.13% down from its 52 week high and 91.65% up from its 52 week low.

What is Nuvation Bio's market capitalisation today?

Nuvation Bio market capitalisation is $0.00T as on .

How to invest in Nuvation Bio Stock (NUVB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Nuvation Bio on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nuvation Bio Shares that will get you 0.2613 shares as per Nuvation Bio share price of $5.74 per share as on September 26, 2026 at 8:45 am IST.

What is the minimum amount required to buy Nuvation Bio Stock (NUVB) from India?

Indian investors can start investing in Nuvation Bio (NUVB) shares with as little as ₹95.8125 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.13 in Nuvation Bio stock (as per the Rupee-Dollar exchange rate as on ). Based on Nuvation Bio share’s latest price of $5.74 as on September 26, 2026 at 8:45 am IST, you will get 1.7422 shares of Nuvation Bio. Learn more about fractional shares .

What are the returns that Nuvation Bio has given to Indian investors in the last 5 years?

Nuvation Bio stock has given -38.54% share price returns and 29.49% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?